Position in PGEN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,700
+$1,830 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#187
of 210 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADIRONDACK TRUST CO holds $508,583 across 8 Biotechnology names. PGEN ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
375 | $233,827 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
443 | $220,051 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
2,500 | $36,425 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
188 | $7,333 | |
| 5 | PGEN |
Precigen, Inc.
This page
|
1,000 | $5,700 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
516 | $4,318 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
25 | $503 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
43 | $426 |
All Filings in PGEN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,700 | 1,000 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,870 | 1,000 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $4,180 | 1,000 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,290 | 1,000 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,420 | 1,000 | Shares | Sole | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||